Hologic, Inc. (0J5Q.L)
USD 72.51
(-0.3%)
USD 72.51
(-0.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.02 Billion USD | -2.34% |
| 2023 | 4.12 Billion USD | -1.73% |
| 2022 | 4.19 Billion USD | -10.77% |
| 2021 | 4.7 Billion USD | 4.74% |
| 2020 | 4.48 Billion USD | 3.75% |
| 2019 | 4.32 Billion USD | -9.91% |
| 2018 | 4.8 Billion USD | -7.56% |
| 2017 | 5.19 Billion USD | 0.4% |
| 2016 | 5.17 Billion USD | -6.99% |
| 2015 | 5.56 Billion USD | -12.41% |
| 2014 | 6.35 Billion USD | -10.02% |
| 2013 | 7.05 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3.93 Billion USD | 1.79% |
| 2024 Q2 | 3.87 Billion USD | 1.42% |
| 2024 Q1 | 3.81 Billion USD | -7.44% |
| 2024 Q4 | 4.02 Billion USD | 2.2% |
| 2023 Q3 | 4.15 Billion USD | 0.19% |
| 2023 Q4 | 4.12 Billion USD | -0.81% |
| 2023 FY | 4.12 Billion USD | -1.73% |
| 2023 Q1 | 4.19 Billion USD | 0.07% |
| 2023 Q2 | 4.14 Billion USD | -1.19% |
| 2022 Q1 | 4.76 Billion USD | 1.38% |
| 2022 FY | 4.19 Billion USD | -10.77% |
| 2022 Q4 | 4.19 Billion USD | -3.77% |
| 2022 Q3 | 4.35 Billion USD | -7.67% |
| 2022 Q2 | 4.72 Billion USD | -0.93% |
| 2021 Q1 | 4.28 Billion USD | -4.61% |
| 2021 Q3 | 4.71 Billion USD | 10.93% |
| 2021 Q4 | 4.7 Billion USD | -0.26% |
| 2021 FY | 4.7 Billion USD | 4.74% |
| 2021 Q2 | 4.24 Billion USD | -0.76% |
| 2020 Q3 | 4.54 Billion USD | -3.93% |
| 2020 Q4 | 4.48 Billion USD | -1.23% |
| 2020 FY | 4.48 Billion USD | 3.75% |
| 2020 Q1 | 4.05 Billion USD | -6.29% |
| 2020 Q2 | 4.73 Billion USD | 16.68% |
| 2019 Q3 | 4.3 Billion USD | -1.37% |
| 2019 FY | 4.32 Billion USD | -9.91% |
| 2019 Q4 | 4.32 Billion USD | 0.48% |
| 2019 Q2 | 4.36 Billion USD | -3.78% |
| 2019 Q1 | 4.53 Billion USD | -5.52% |
| 2018 FY | 4.8 Billion USD | -7.56% |
| 2018 Q3 | 4.64 Billion USD | -3.07% |
| 2018 Q4 | 4.8 Billion USD | 3.45% |
| 2018 Q1 | 4.85 Billion USD | -6.56% |
| 2018 Q2 | 4.78 Billion USD | -1.35% |
| 2017 FY | 5.19 Billion USD | 0.4% |
| 2017 Q1 | 5.1 Billion USD | -1.26% |
| 2017 Q2 | 5.9 Billion USD | 15.66% |
| 2017 Q3 | 5.25 Billion USD | -11.12% |
| 2017 Q4 | 5.19 Billion USD | -1.09% |
| 2016 FY | 5.17 Billion USD | -6.99% |
| 2016 Q4 | 5.17 Billion USD | -1.7% |
| 2016 Q3 | 5.26 Billion USD | 0.42% |
| 2016 Q2 | 5.24 Billion USD | -4.92% |
| 2016 Q1 | 5.51 Billion USD | -0.9% |
| 2015 FY | 5.56 Billion USD | -12.41% |
| 2015 Q4 | 5.56 Billion USD | -5.6% |
| 2015 Q3 | 5.89 Billion USD | 0.52% |
| 2015 Q2 | 5.86 Billion USD | -1.88% |
| 2015 Q1 | 5.97 Billion USD | -5.92% |
| 2014 FY | 6.35 Billion USD | -10.02% |
| 2014 Q4 | 6.35 Billion USD | -0.45% |
| 2014 Q3 | 6.38 Billion USD | -0.02% |
| 2014 Q2 | 6.38 Billion USD | -2.32% |
| 2014 Q1 | 6.53 Billion USD | -7.44% |
| 2013 Q4 | 7.05 Billion USD | -3.78% |
| 2013 Q3 | 7.33 Billion USD | 0.24% |
| 2013 Q2 | 7.31 Billion USD | -2.21% |
| 2013 Q1 | 7.48 Billion USD | 0.0% |
| 2013 FY | 7.05 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -3265.208% |
| Accuray Incorporated | 423.54 Million USD | -850.553% |
| Align Technology, Inc. | 2.45 Billion USD | -64.1% |
| Elevance Health Inc. | 69.52 Billion USD | 94.209% |
| AxoGen, Inc. | 101.16 Million USD | -3879.755% |
| Boston Scientific Corporation | 15.6 Billion USD | 74.202% |
| CVS Health Corporation | 173.09 Billion USD | 97.674% |
| Cardinal Health, Inc. | 48.33 Billion USD | 91.67% |
| Centene Corporation | 58.68 Billion USD | 93.14% |
| DaVita Inc. | 14.87 Billion USD | 72.937% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 92.7% |
| Humana Inc. | 30.74 Billion USD | 86.906% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -126.766% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 54.429% |
| Masimo Corporation | 1.67 Billion USD | -140.115% |
| McKesson Corporation | 69.04 Billion USD | 94.169% |
| Patterson Companies, Inc. | 1.89 Billion USD | -112.454% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 47.054% |
| ResMed Inc. | 2 Billion USD | -100.463% |
| Henry Schein, Inc. | 5.42 Billion USD | 25.72% |
| Teladoc Health, Inc. | 2.06 Billion USD | -94.841% |
| Universal Health Services, Inc. | 8.15 Billion USD | 50.631% |
| Veeva Systems Inc. | 1.26 Billion USD | -217.985% |
| Baxter International Inc. | 19.8 Billion USD | 79.675% |
| Becton, Dickinson and Company | 26.98 Billion USD | 85.08% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -96.947% |
| Danaher Corporation | 30.99 Billion USD | 87.012% |
| Stryker Corporation | 21.31 Billion USD | 81.115% |
| Medtronic plc | 39.56 Billion USD | 89.823% |